Global Medtech Guidance Tracker: July 2022
Executive Summary
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-five documents have been posted on the tracker since its last update.
You may also be interested in...
Remote Regulatory Assessments Will Continue Post Pandemic, Says US FDA
The US FDA has issued guidance on how it will continue to use remote technology to assess agency regulated facilities, a practice that became popular during COVID-19 travel restrictions.
Companies Get Alternative Options For IVDs Pending A Fully-Functional Eudamed
With news that new version of the European Commission’s Eudamed medical devices database is not going to be fully ready until the second quarter of 2024 two years after the full application of the IVDR on 26 May new EU guidance has been published to help IVD manufacturers understand in detail what they should do in the meantime.
Saudi FDA Finalizes Approach To Commercial Info In Public Assessment Reports
Saudi Arabia has explained what information on a drug’s review will be made public following a marketing authorization decision.